drugset / Trial / NCT02265913

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913

Phase 3 Completed 4076 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare safety and efficacy of Perrigo's antiviral drug product compared to an FDA approved antiviral drug product in the treatment of cold sores.

Timeline

Start
2014-10-06
Primary completion
2016-04-27
Completion
2017-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyclovir Small molecule 5 %

Indications